Related Experiment Videos
Exploring the influence of insurance effects on prescription drug coverage
Patrick L McKercher1, Stephanie D Taylor
1Center for Medication Use, Policy & Economics, University of Michigan, Ann Arbor, USA.
The Annals of Pharmacotherapy
|November 16, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Characteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis.
Rheumatology and therapy·2024
Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility Values.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2024
Economic and Health Care Resource Use Burden of Systemic Sclerosis.
ACR open rheumatology·2023
Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study.
Journal of managed care & specialty pharmacy·2019
Inadequate pain relief among patients with primary knee osteoarthritis.
Revista brasileira de reumatologia·2017
Efficacy and Safety of Fremanezumab in Episodic Migraine: A Systematic Review and Meta-analysis.
The Annals of pharmacotherapy·2026
Efficacy and Safety of Baxdrostat in Hypertension: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
The Annals of pharmacotherapy·2026
Efficacy and Safety of Linaclotide in Pediatric Patients of Functional Constipation: A Meta-analysis of Randomized Controlled Trials.
The Annals of pharmacotherapy·2026
Apixaban Dose Selection in Kidney Failure: Reconciling Pharmacokinetics and Clinical Outcomes.
The Annals of pharmacotherapy·2026
Impact of Duration of Intravenous Octreotide Infusion on Achieving Hemostasis in Patients With Acute Variceal Hemorrhage.
The Annals of pharmacotherapy·2026
Determinants of generalized trust: Economic, Institutional, and personal factors.
Open research Europe·2026
The 2025 European health data space regulation: implementation challenges in harmonising opt-out rules for reusing health data.
Health policy (Amsterdam, Netherlands)·2026
Private Equity Investment in Substance Use Disorder Treatment Facilities and Opioid- and Alcohol-Related Mortality.
Psychiatric services (Washington, D.C.)·2026
New Medicaid State-Directed Payment Limits Are Likely To Decrease Medicaid Spending By 10-25 Percent In 17 States.
Health affairs (Project Hope)·2026
Selective visibility in datafied states: Examining the absence and presence of the European Health Data Space.
Social science & medicine (1982)·2026